Wrinkle Injections: BOTOX ~ for Wrinkle Injections

Wrinkle Injections: BOTOX ~ for Wrinkle Injections

South Korea Patent Allowance for Anti-Obesity Pet Vaccines to Braasch Biotech LLC

Braasch Biotech granted Anti-Obesity patent for pets by Korean Intellectual Property  Office. Commercial utility and novelty for first therapeutic vaccine for use in  obese dogs, cats and horses. Garretson, SD, June 11, 2016 --(PR.com)-- Braasch Biotech LLC,  an emerging biopharmaceutical company pioneering a new field  of anti-somatostatin vaccines, today announced a Notice of Allowance  was received from the South Korean Intellectual Property Office for Braasch’ s patent entitled “Compositions and methods for enhanced somatostatin  immunogenicity.” Working in the area of therapeutic vaccines for  non-infectious conditions, the currently described methods target adult onset obesity. The Patent Allowance provides claims for the therapeutic treatment for  obesity in dogs, cats and horses. The source of obesity includes both  diabetic and non-diabetic causes. The Braasch vaccine technologies,  like other veterinary vaccines, utilize specific immunological responses  post-vaccination. In the case of the Braasch vaccine, the endogenous  hormone somatostatin is targeted. By attenuating the effects  of this counter-regulatory hormone, a therapeutic effect on obesity is realized. “Like human obesity, obesity in dogs and cats is at epidemic proportions.  Although prevention is always the best option, once an animal reaches  the obese state, owner intervention is necessary for the pet’s continued  quality of life and longevity. Currently there are no commercially  available therapeutic treatments for both dogs and cats,” stated  Jeralyn Kay Haffer, CEO and Chairman of Braasch. “We are now  pleased the Korean Intellectual Property Office also has recognized the  vaccine’s novelty and commercial utility in the fight against obesity.” Braasch’s intellectual property portfolio includes multiple patent families  with issued or pending claims directed to utility of anti-somatostatin  vaccine technologies, Somatovac® for multiple metabolic challenges.  These applications relate to both human and veterinary use of the technologies. About Braasch Biotech Braasch Biotech is a biopharmaceutical company with a focus on the  development and commercialization of innovative products of therapeutic  approaches utilizing Somatovac® technologies. Currently in the Product  Pipeline are vaccines for livestock productivity enhancement, increased  fertility, GH/IGF-1 deficiencies and obesity treatment. To date, Braasch  has multiple regulatory submissions in progress on the use of vaccines  in metabolic regulation. Braasch Biotech is a privately held  biopharmaceutical with corporate offices in South Dakota. email info@braaschbiotech.com or visitwww.braaschbiotech.com. Contact Information Jeralyn Kay Haffer CEO and Chairman Tel. 605-376-8752 Fax. 605-594-6256 jeralyn@braaschbiotech.com

Combating the over-medication of seniors

Seniors are particularly vulnerable to the effects of too many prescriptions

By Alan Cassels
Advisor
EvidenceNetwork.ca

VICTORIA, B.C. / Troy Media/ - Working aggressively to reduce their daily medication burden may be the single best thing we can do to improve the quality of life of our aging parents and grandparents.

The issue of too much medication in Canadian seniors is finally starting to be recognized as the serious problem it has become. Seniors are particularly vulnerable to the adverse effects of too many prescription drugs because aging affects their ability to process medications.

The statistics behind polypharmacy in the elderly - the term describes the simultaneous use of multiple medications - are surprising. In Canada, nearly 70 per cent of all seniors take five or more drugs and almost 10 per cent take 15 or more medications.

Many hospitalizations in the elderly are caused by adverse medication reactions, according to several recent studies. And one of the biggest health hazards for seniors is falling - often a result of multiple medications, which can cause cognitive difficulties and affect balance.

The good news is awareness of the scale of the problem is growing. More and more physicians are initiating "deprescribing" discussions with their older patients. "Deprescribing" is simply the deliberate and conscientious stopping or tapering of prescriptions to help improve health outcomes.

Some long-term care facilities are now required to do periodic medication reviews and weed out unnecessary, ineffective or hazardous pills. A recent massive  Canadian Foundation for Healthcare Improvement project has shown how to reduce the inappropriate prescribing of antipsychotic medications to seniors with dementia.

Programs, research initiatives and physician education activities on deprescribing are being carried out in most provinces. Canada's new Deprescribing Network is developing tools and information to help make deprescribing commonplace and part of the prescribing culture.

This is all a step in the right direction. Unfortunately, there's still reluctance in some quarters to cut back on medications.

Some health care providers have shown themselves to be nervous when initiating deprescribing activities, worried that they are reducing medications that specialists or other doctors have ordered. Publicly-funded medication reviews conducted by pharmacists can be flawed too, a CBC Marketplace investigation has found. Some reviews may be motivated by business reasons, resulting in more, not fewer pills for patients. The same report noted that even when done properly, medication reviews often miss the very patients who would benefit most from a review, such as the elderly or people on a high number of medications.

More than 90 per cent of seniors say they want to reduce their medications if a doctor suggests it. And who can blame them? No one wants to be on a potentially expensive medication with possible side-effects and possible risks if they don't absolutely require it.

So what should be done?

Consumer-oriented literature on medicine tends to focus on adherence and compliance to medications and not necessarily more appropriate drug treatment. And we can't forget that pharmaceutical manufacturers have a business incentive for volume and are not rewarded for appropriateness of prescribing.

Thankfully, the folks from the Canadian Deprescribing Network have identified a few areas where they see the harms of drugs often exceeding the benefits. These include, but are not limited to, benzodiazepines and other sedative medications (commonly prescribed for sleeping), proton pump inhibitors (to treat ulcers and heartburn) and sulphonylureas (to treat type-II diabetes).

Drugs that can be problematic in combination with other medications include those that treat blood pressure and glucose, where high doses of multiple medications can lead to problems. They also flag the over-use of blood thinners - which require appropriate monitoring. According to the network, these are good places to start a consultation with your doctor.

If you want to join the deprescribing revolution, don't do it by yourself. Have a conversation with your doctor or pharmacist, who will be able to help you decide if you are on the appropriate medications, which medications could be safely reduced or eliminated and how to do so.

As people get older, they should constantly ask if a new medication is going to affect the things that are important to them: their mobility, cognitive abilities and capacity to enjoy life.

Caregivers and seniors, most importantly, have to be ready to assert their wishes when it comes to taking too many medications and always be alert to the possibility that more medication might mean more problems.

Alan Cassels is an advisor with the Evidence Network and a pharmaceutical policy researcher in Victoria, B.C. He's the author of the newly published The Cochrane Collaboration: Medicine's Best Kept Secret.

© 2016 Distributed by Troy Media

Four Easy, Beach-Picnic-Ready Recipes

Four Easy, Beach-Picnic Ready Recipes

Nothing says summer like a day at the beach, but coming up with a menu that’s both portable and delicious can be tricky. Here, we put together some recipes that are fairly easy to prep and perfect for alfresco dining. If you’re bringing the whole family, we recommend throwing in some easy pesto pasta and sliced watermelon for dessert. Pack up a cooler bag and some enamel or disposable serving dishes (we’re currently into these chic compostable ones out of Japan) and you’re set.

The - Beauty Makers: INDERMICA Oxyderm Wrinkle Cream

The - Beauty Makers: INDERMICA Oxyderm Wrinkle Cream: www.indermica.com